| Reversal of indoleamine 2, 3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme TA Triplett, KC Garrison, N Marshall, M Donkor, J Blazeck, C Lamb, ... Nature biotechnology 36 (8), 758-764, 2018 | 235 | 2018 |
| Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse H Zang, M Siddiqui, S Gummuluru, WW Wong, BM Reinhard ACS Nano, 2022 | 11 | 2022 |
| Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme J Blazeck, CS Karamitros, K Ford, C Somody, A Qerqez, K Murray, ... Nature catalysis 5 (10), 952-967, 2022 | 10 | 2022 |
| Small molecule-inducible gene regulatory systems in mammalian cells: progress and design principles M Siddiqui, C Tous, WW Wong Current Opinion in Biotechnology 78 (December 2022), 2022 | 9 | 2022 |
| Engineering universal chimeric antigen receptor systems to expand cell therapy applications MY Siddiqui | | 2023 |
| Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme BT Lu, C Lamb, Y Tanno, MY Siddiqui, N Ashoura, S Coma, XM Zhang, ... | | |
